GlaxoSmithKline’s diabetes drug Avandia will increase cardiac risks while Takeda’s Actos may reduce cardiac risks. These research results were published in the latest edition of Journal of the American Medical Association. The research was done on 14,000 patients in 4 clinical trials over 1 year period. Actos protect patients from [...]
Blood pressure drugs protect diabetic hearts
September 5, 2007 By Leave a Comment
According to new research reports, Diuretic and Angiotensin converting enzyme inhibitor (ACE) combination protect diabetic patients from heart diseases. This combination drug therapy reduces heart disease risk by 18%. Researchers used ACE Inhibitor (Perindopril, 2mg) and Diuretic (Indapamide, 0.625 mg) in the research studies. This therapy reduces risk from both macro vascular and micro [...]
Diabetes: Diet and Blood tests
August 10, 2007 By Leave a Comment
Diabetes can damage the blood vessels, including the arteries that supply blood to the brain. This damage makes it easier for fatty deposits (plaques) to form in the arteries. The build-up of arterial plaques (atherosclerosis) can choke off blood supply to raise the blood pressure, leading to coronary heart disease. Timings [...]
Avandia may cause Heart disease
May 22, 2007 By Leave a Comment
According to the study published in New England Journal of Medicine, Avandia, drug used in Type2 diabetes, increases the risk of cardiac-related fatalities by 64 per cent % and heart attacks by 43%. Avandia (Rosiglitazone) is in use since 1999 to treat Type2 diabetes generally in combination with Metformin or Glimipride. The study [...]
Recent Comments